First-line AML: does add-on clofarabine improve survival in young adults?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Clofarabine reduces risk for relapse in younger adults with previously untreated acute myeloid leukemia (AML), but only improves survival in selected groups of intermediate-risk patients with AML.

Why this matters

  • Clofarabine has not previously been evaluated in first-line the...